Betmiga 25 mg prolonged-release tablets

Company
Astellas Pharma Co. Ltd
Active Ingredient
Dosage Form
Prolonged-release tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/12/809/001 25 milligram(s) G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/002 25 milligram(s) G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/003 25 milligram(s) G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/004 25 milligram(s) G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/005 25 milligram(s) G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/006 25 milligram(s) G04BD, G04BD12 Prolonged-release tablet
EU/1/12/809/007 25 milligram(s) G04BD, G04BD12 Prolonged-release tablet
Licence number
EU/1/12/809/001
Strength
25 milligram(s)
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/002
Strength
25 milligram(s)
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/003
Strength
25 milligram(s)
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/004
Strength
25 milligram(s)
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/005
Strength
25 milligram(s)
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/006
Strength
25 milligram(s)
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet
Licence number
EU/1/12/809/007
Strength
25 milligram(s)
ATC Code
G04BD, G04BD12
Dosage Form
Prolonged-release tablet

Astellas Pharma Co. Ltd

Damastown Road, Damastown Industrial Park, Mulhuddart, Dublin 15